Fact CheckerSign in

NCT07773194Completed

Progressive Muscle Relaxation and Deep Breathing Exercises in Patients With COPD

The Effect of Progressive Muscle Relaxation and Deep Breathing Exercises on Fatigue and Sleep Quality in Patients With COPD: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 19 Aug 2026

Brief summary (registry, in English)

This randomized controlled trial evaluated the effects of progressive muscle relaxation and deep breathing exercises on fatigue and sleep quality in patients with chronic obstructive pulmonary disease (COPD). A total of 90 patients were assigned to three groups: a progressive muscle relaxation exercise group, a deep breathing exercise group, and a control group. Participants in the intervention groups were taught their assigned exercises individually and were instructed to practice them daily at home for 8 weeks. The control group received no study intervention during this period. Fatigue and sleep quality were assessed before the intervention and at the end of the 8-week study period.

Status (registry)
Completed
Study type
Interventional
Enrollment
90 (actual)
First submitted
14 Aug 2026
Start date
15 Feb 2025
Primary completion date
15 Jan 2026
Lead sponsor
Firat University
Diseases
COPD
NCT number
NCT07773194

What you commit to

  • Study type: Interventional
  • Participants enrolled: 90
  • From 15 Feb 2025 to the primary completion date, 15 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of a perceptual disorder or psychiatric condition that impairs communication.
    • Presence of a serious complication related to COPD.

Who the study is looking for

  • Diagnosed with chronic obstructive pulmonary disease (COPD) according to GOLD criteria at least 6 months before enrollment.
    • Able to communicate verbally. No severe hearing or visual impairment. No serious medical condition or serious complication related to COPD.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gül DURAL
Coordinator of this site? Confirm its status
ElâzığTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.